These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 37477517)

  • 1. CircACTR2 promotes bladder cancer progression through IKBKB-mediated NF-κB signaling pathway activation.
    Li P; Zhao Z; Chen Q; Liu Y; Sun G; Chen J; Jia R; Ge J
    Heliyon; 2024 Jun; 10(11):e30778. PubMed ID: 38882353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF-
    Ji X; Cheng K; Gao C; Xie H; Zhu R; Luo J
    Biomed Res Int; 2022; 2022():5509346. PubMed ID: 35909476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insight into the potential functional role of pseudoenzyme GFOD1 via interaction with NKIRAS2.
    Shi J; Guo X; Liu C; Wang Y; Chen X; Wu G; Ding J; Zhang T
    Acta Biochim Biophys Sin (Shanghai); 2024 Jul; ():. PubMed ID: 38946427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "PRMT5-activated c-Myc promote bladder cancer proliferation and invasion through up-regulating NF-κB pathway" [Tissue Cell 76 (2022) 101788].
    Zhang L; Shao G; Shao J; Zhao J
    Tissue Cell; 2023 Dec; 85():102221. PubMed ID: 37923634
    [No Abstract]   [Full Text] [Related]  

  • 5. SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells.
    Shi Z; Zhang H; Shen Y; Zhang S; Zhang X; Xu Y; Sun D
    Thorac Cancer; 2023 Sep; 14(25):2579-2590. PubMed ID: 37548102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer.
    Kudling TV; Clubb JHA; Pakola S; Quixabeira DCA; Lähdeniemi IAK; Heiniö C; Arias V; Havunen R; Cervera-Carrascon V; Santos JM; Sutinen E; Räsänen J; Borenius K; Mäyränpää MI; Aaltonen E; Sorsa S; Hemminki O; Kanerva A; Verschuren EW; Ilonen I; Hemminki A
    Oncoimmunology; 2023; 12(1):2241710. PubMed ID: 37546696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study.
    Dong D; Zhang S; Jiang B; Wei W; Wang C; Yang Q; Yan T; Chen M; Zheng L; Shao W; Xiong G
    Front Oncol; 2023; 13():1222716. PubMed ID: 37546402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
    Tonneau M; Phan K; Manem VSK; Low-Kam C; Dutil F; Kazandjian S; Vanderweyen D; Panasci J; Malo J; Coulombe F; Gagné A; Elkrief A; Belkaïd W; Di Jorio L; Orain M; Bouchard N; Muanza T; Rybicki FJ; Kafi K; Huntsman D; Joubert P; Chandelier F; Routy B
    Front Oncol; 2023; 13():1196414. PubMed ID: 37546399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab-Associated Stevens-Johnson Syndrome in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report.
    Sandhu M; Kc B; Bhandari J; Gambhir HS; Farah R
    Cureus; 2023 Jul; 15(7):e41439. PubMed ID: 37546048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0006324 regulates cell proliferation, cell-cycle progression, apoptosis, and glycolysis of non-small cell lung cancer cells through miR-496/TRIM59 axis.
    Wang T; Zhu X; Wang K; Ding R
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23473. PubMed ID: 37545326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRF2 participates in the suppressive tumor immune microenvironment of KRAS/KEAP1 co-mutant non-small cell lung cancer by inhibiting the STING pathway.
    Xiaodan S; Peiyan Z; Hui L; Yan L; Ying C
    Genes Dis; 2023 Sep; 10(5):1727-1730. PubMed ID: 37492744
    [No Abstract]   [Full Text] [Related]  

  • 12. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA circ_0008037 facilitates tumor growth and the Warburg effect via upregulating NUCKS1 by binding to miR-433-3p in non-small cell lung cancer.
    Yu J; Zhang H; Zhao C; Li G; Zhang Y; Sun Y
    Thorac Cancer; 2022 Jan; 13(2):162-172. PubMed ID: 34850570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
    Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
    Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0003528 promotes cell malignant transformation and immune escape via increasing oncogene PDL1 through sponging miR-511-3p in non-small cell lung cancer.
    Wang G; Deng L; Gong K; Zhou P; Peng L; Li C
    Environ Toxicol; 2023 Jun; 38(6):1347-1360. PubMed ID: 36947452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0001955 promotes non-small cell lung cancer cell proliferation and invasion by regulating MiR-29a-3p/NKIRAS2 axis to activate the nuclear factor-κB pathway.
    Zhou X; Qiu G; Yang Y; Bao W; Zhang D; Du X
    Pathol Int; 2023 Sep; 73(9):434-443. PubMed ID: 37477517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
    Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
    Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.